A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... disease (COPD). Sales of Breztri ...

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...

Opens in a new tab or window Share on Bluesky ... "This may inform prescribing of glucose-lowering medications among patients with T2D and active COPD," making SGLT2 and GLP-1 drugs preferable ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This in-depth analysis shows that the Global Asthma and COPD Drugs Market, valued at ...

Large numbers of hospital admissions, along with poor adherence and the prescribing of inappropriate inhalers mean ... number of new drugs available for asthma and COPD, HCPs are increasingly ...

BREZTRI AEROSPHERE is for regular long-term use only. You should have a separate reliever inhaler to treat ... to be started on any new medicine (including any for COPD or other lung/breathing ...

BOONE, N.C.--(BUSINESS WIRE)--Pneuma Respiratory, a med-tech and pharmaceutical company dedicated to advancing inhaled respiratory therapeutics, is introducing new transformational approaches to ...

Starting with Breztri, our triple combination inhaler, already approved in COPD. We have the opportunity to improve care for people suffering from uncontrolled asthma with a new treatment option.

AZN earnings call for the period ending December 31, 2024.

Not long after, while the world was still coping with the COVID-19 pandemic, Lyn was diagnosed with chronic obstructive pulmonary disease (COPD), and given various inhalers to try and ... 2 weeks on ...